GALLI, NICOLE
GALLI, NICOLE
Universita' degli Studi di MILANO
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.0 secondi).
Reply to: Can circulating CD34+ cells count be used for the prognosis of myelofibrosis? Probably yes, at least in patients treated with ruxolitinib
2023 A. Iurlo, N. Galli, C. Bucelli, S. Artuso, D. Consonni, D. Cattaneo
Trend of circulating CD34+ cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment
2023 A. Iurlo, N. Galli, C. Bucelli, S. Artuso, D. Consonni, D. Cattaneo
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis
2022 D. Cattaneo, C. Vener, E.M. Elli, C. Bucelli, N. Galli, F. Cavalca, G. Auteri, D. Vincelli, B. Martino, U. Gianelli, F. Palandri, A. Iurlo
Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
---|---|---|---|---|---|
Reply to: Can circulating CD34+ cells count be used for the prognosis of myelofibrosis? Probably yes, at least in patients treated with ruxolitinib | 2023 | Galli, NicoleCattaneo, Daniele + | Article (author) | - | |
Trend of circulating CD34+ cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment | 2023 | Galli, NicoleCattaneo, Daniele + | Article (author) | - | |
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis | 2022 | Cattaneo D.Vener C.Galli N.Gianelli U. + | Article (author) | - |